Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures -- Ignore unavailable to you. Want to Upgrade?

To: ~digs who wrote (1472)	9/10/2005 5:22:50 PM
From: ~digs	Respond to of 7944

ARDM 1.15 stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G Aradigm Corporation engages in the development and commercialization of noninvasive drug delivery systems. It develops needle-free drug delivery systems that enable patients to self-administer liquid drugs that would otherwise be given by injection. The company offers hand-held AERx technology for the rapid and reproducible delivery of a range of pharmaceutical drugs and biotech compounds through the lung, as well as pen-sized, needle-free Intraject system to deliver drugs to the subcutaneous layer of the skin. Aradigm also provides AERx insulin Diabetes Management System, which permits patients with diabetes to noninvasively self-administer insulin. Its other early-stage AERx programs include liposomal ciprofloxacin under agreement with Canada’s Department of Defence; Hydroxycholoroquine for the treatment of asthma and an undisclosed drug that targets a common respiratory disease NKBS 2.4 stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G Sept. 9 /PRNewswire-FirstCall/ -- Newtek Business Services, Inc. (Nasdaq: NKBS - News; www.newtekbusinessservices.com), a provider of business services and financial products to the small to medium-sized business market, today announced that Barry Sloane, Chairman and CEO, will be presenting at this year's Friedland Investment Events' Undervalued Equities 2005 conference at 10:45am on September 13. The financial conference will be held at the DoubleTree Suites Times Square Hotel in New York City on September 13, 2005. RAE 3.7 stockcharts.com[w,a]daclyiay[pc40!c200!f][vc60][iut!La12,26,9!Ll14]&pref=G RAE Systems, Inc. engages in the development and manufacture of deployable multisensor chemical detection monitors and networks for homeland security and industrial applications primarily in the United States. The company offers portable single-sensor chemical and radiation detection products, portable single and multiple sensor atmospheric monitors, integrated systems, photo-ionization detectors, indoor air quality and security monitors, gas detection tubes, and sampling pumps. In addition, its technologically advanced products include portable, wireless, fixed chemical detection monitors, and gamma and neutron detectors. The company products enable the military and first responders, such as firefighters, law enforcement, and other emergency management personnel to detect and provide warning of weapons of mass destruction and other hazardous materials. Its industrial applications include the detection of toxic industrial chemicals, volatile organic compounds, and petrochemicals.